Menu Search
Equities

Aoxing Pharmaceutical Company Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
AOXG:PKC

Aoxing Pharmaceutical Company Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.0038
  • Today's Change-0.001 / -24.00%
  • Shares traded115.00k
  • 1 Year change-55.81%
  • Beta--
Data delayed at least 15 minutes, as of Feb 11 2026 14:31 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.

  • Revenue in USD (TTM)30.11m
  • Net income in USD-1.46m
  • Incorporated1996
  • Employees339.00
  • Location
    Aoxing Pharmaceutical Company Inc1098 Foster City Blvd Ste 106-810FOSTER CITY 94404United StatesUSA
  • Phone+1 (646) 367-1747
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.